The Fine Chemicals business of Albemarle saw a 23% increase in sales in Q4 2008 to $161.3m. The company said the rise was due to "increased volume and pricing from fine chemistry services and improved pricing from our bromine portfolio". The company's Fine Chemicals segment reported a record income for the year.
Forbes
Tuesday 27 January 2009
Albemarle sees record fine chemicals income
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment